معرفی
Tor Olofsson serves as an Associate Professor and Physician at Lund University's Faculty of Medicine within the Department of Rheumatology. He is an active member of the Lund Arthritis Research Group (LARG) with significant contributions to rheumatology research, particularly in rheumatoid arthritis, pain management, and TNF inhibitor therapies.
- Associate Professor, Faculty of Medicine
- Physician specializing in Rheumatology
- Member, Lund Arthritis Research Group (LARG)
- Active researcher with 32 publications
Dr. Olofsson's research primarily focuses on inflammatory arthritis, pain mechanisms, and treatment effectiveness. His work examines patient-reported outcomes, disease activity assessment, and the relationship between inflammatory markers and pain in rheumatoid arthritis patients. He investigates how early intervention affects long-term outcomes and explores the complex relationship between inflammatory and non-inflammatory pain mechanisms in arthritis patients.
His research has been recognized with the Bundy Academys Lilla Pris award for 2025, highlighting his contributions to understanding inflammatory pain, fibromyalgia, and inflammatory arthritis. His work has garnered attention across multiple platforms with mentions in news outlets, social media, and academic sharing networks.
- Bundy Academys Lilla Pris 2025 for research on inflammatory pain and fibromyalgia
- Featured in multiple news outlets and academic sharing platforms
- Significant social media engagement across X (Twitter) platforms
- Widely read on academic platforms like Mendeley
Dr. Olofsson actively supervises doctoral research as third supervisor for the project 'Pain in rheumatoid arthritis - predictors and change over time.' He leads the research project 'Fibromyalgia and non-inflammatory pain in inflammatory arthritis – prevalence, biomarkers and effects: can the occurrence be prevented by early inflammation control' funded by Alfred Österlunds stiftelse and the Swedish Rheumatology Association. Additionally, he contributes as a researcher to the TINDRA project on tight control in newly developed rheumatoid arthritis, supported by multiple foundations including Familjen Kamprads Stiftelse and the Swedish Rheumatology Association.
His collaborative network spans multiple European countries, with significant research partnerships across Scandinavia and continental Europe. His work frequently appears in high-impact rheumatology journals and contributes to the UN Sustainable Development Goals related to good health and well-being.
